A Randomized Phase 3 Open Label Study of Nivolumab vs Temozolomide Each in Combination with Radiation Therapy in Newly Diagnosed Adult Subjects with Unmethylated MGMT (tumor O6-methylguanine DNA methyltransferase) Glioblastoma - Regional Cancer Care Associates LLC

Clinical Trials

A Randomized Phase 3 Open Label Study of Nivolumab vs Temozolomide Each in Combination with Radiation Therapy in Newly Diagnosed Adult Subjects with Unmethylated MGMT (tumor O6-methylguanine DNA methyltransferase) Glioblastoma

Type of Cancer
Neuro-Oncology
Locations
Hackensack
Sponsor
Bristol-Myers Squibb
Protocol Number
CA209-498
Cancer Diagnosis
To Learn More Call
201-510-0910